BURBANK, CA / ACCESSWIRE / February 6, 2015 / Imaging3(TM), Inc. (IMGGQ) announces today that it has entered into an agreement with the accountants and advisors of the firm Rose, Snyder & Jacobs LLP, with the goal of bringing Imaging3's SEC financial reports current and obtaining a trading symbol through FINRA so that it can reemerge as a publicly traded company. Dane Medley, Chairman/CEO of Imaging3, commented, "While we cannot assure that Imaging3 will be successful in reemerging as a public company, the engagement of a new outside accounting firm represents an important step in our path to reemergence."
Imaging3 also announces that its Board of Directors ratified the proposed acquisition and stock purchase of a California-based privately owned rental company that caters to the Medical and B2B marketplace. The transaction has been agreed to verbally by both parties and is currently expected to be completed during the first quarter of 2015. Imaging3 will announce the name of the company as soon as it is permitted to do so under the parties' nondisclosure agreement. Medley commented, "We are working to develop share value for the company with a new business model and are pursuing several strategic acquisitions and other business transactions in 2015. Our objective is to continue adding value towards our core competencies while enhancing and broadening our product and service offerings.
Imaging3 has recently become the exclusive EnvisionTEC dealer for California for professional grade 3D printers and FDA approved medical bio plotters. EnvisionTEC is becoming a world leader in 3D printer manufacturing specializing in rapid prototyping and equipment, across a variety of markets. Imaging3 will be launching a new marketing campaign in the near future, with more details on this exciting new opportunity. Mr. Medley commented "EnvisionTEC has an excellent track record and is growing its dealer base across the US. We are excited to be partnered with an up and coming leader in the 3D market space."
Imaging3 is also completing software upgrades on the Dominion VI scanner, with a goal of resubmitting Imaging3's 510(k) application to the Food and Drug Administration later this year. This process will be managed by an outside consulting firm to help expedite the FDA process. Medley stated, "We are excited at the developments and enhancements made to date as we progress towards reaching our goal of obtaining FDA approval."
